The World Health Organization (WHO) hailed as "incredible news" introductory clinical preliminary outcomes that demonstrated a modest and generally utilized steroid called dexamethasone can help spare the lives of fundamentally sick COVID-19 patients.
<blockquote>"This is the primary treatment to be appeared to decrease mortality in patients with COVID-19 requiring oxygen or ventilator support," WHO Director-General Tedros Adhanom Ghebreyesus said in an announcement late on Tuesday.

"This is incredible news and I salute the administration of the UK, the University of Oxford, and the numerous medical clinics and patients in the UK who have added to this lifesaving logical discovery."</blockquote>
The specialists shared introductory bits of knowledge about the consequences of the preliminary with WHO, "and we are anticipating the full information investigation in the coming days," it said.

"WHO will facilitate a meta-investigation to expand our general comprehension of this intercession. WHO clinical direction will be refreshed to reflect how and when the medication ought to be utilized in COVID-19," the office included.